Study guide

1.3 Leukocyte Kinetics, Morphology & Phagocytic Function

ASCP Hematology Technologist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Hematopoiesis & Cellular Physiology

1.1 Hematopoiesis, Bone Marrow Microenvironment & Growth Factors 1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways 1.3 Leukocyte Kinetics, Morphology & Phagocytic Function 1.4 Platelet Physiology, Ultrastructure & Thrombopoiesis

2 Chapter 2: Erythrocyte Disorders & Non-Hemolytic Anemias

2.1 Iron Metabolism & Iron Deficiency Anemia 2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity 2.3 Hemoglobinopathies & Qualitative Globin Chain Defects 2.4 Alpha and Beta Thalassemias 2.5 Megaloblastic, Macrocytic & Hypoproliferative Anemias

3 Chapter 3: Hemolytic Anemias & Erythrocytosis

3.1 Intrinsic Hemolytic Anemias: Membrane & Metabolic Defects 3.2 Immune-Mediated Hemolytic Anemias & Paroxysmal Nocturnal Hemoglobinuria 3.3 Non-Immune Extrinsic Hemolytic Anemias & Microangiopathies 3.4 Polycythemia & Erythrocytosis Classification

4 Chapter 4: Benign Leukocyte Alterations, Acute Leukemias & Bone Marrow Evaluation

4.1 Quantitative Leukocyte Alterations, Toxic Change & Leukemoid Reaction 4.2 Inherited Leukocyte Anomalies, Reactive Lymphocytosis & Storage Disorders 4.3 Acute Myeloid Leukemia (AML) & Related Neoplasms 4.4 Acute Lymphoblastic Leukemia (ALL) & Precursor Lymphoid Neoplasms 4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment

5 Chapter 5: Chronic Myeloid Neoplasms, MDS & Mature Lymphoid Neoplasms

5.1 Myelodysplastic Syndromes (MDS) & Overlap Syndromes 5.2 Chronic Myeloproliferative Neoplasms (CML, PV, ET, PMF) 5.3 Chronic Lymphocytic Leukemia & Indolent B-Cell Lymphomas 5.4 Aggressive Lymphomas, Hodgkin Lymphoma & Mature T-Cell Disorders 5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies

6 Chapter 6: Hemostasis: Primary, Secondary & Fibrinolytic Systems

6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders 6.2 Quantitative Platelet Disorders & Immune Thrombocytopenias 6.3 The Coagulation Cascade & Cell-Based Hemostatic Model 6.4 Fibrinolytic System, Natural Anticoagulants & Thrombophilia

7 Chapter 7: Factor Deficiencies, Coagulation Testing & Anticoagulation

7.1 Hereditary Coagulation Factor Deficiencies & von Willebrand Disease 7.2 Acquired Coagulation Factor Deficiencies, Circulating Inhibitors & DIC 7.3 Routine and Specialized Coagulation Testing & Mixing Study Interpretation 7.4 Anticoagulant Therapies, Laboratory Monitoring & Reversal Strategies 7.5 Viscoelastic Testing, Heparin Neutralization & Chromogenic Assays

8 Chapter 8: Hematology Laboratory Testing & Advanced Diagnostics

8.1 Automated Hematology Analyzers, Interference Flags & Manual Methods 8.2 Cytochemical Staining, Flow Cytometry & Molecular Diagnostics 8.3 Erythrocyte Sedimentation Rate, Hemolytic Indicators & Special Erythrocyte Studies 8.4 Cerebrospinal Fluid Analysis, Cell Counts & Cytology 8.5 Serous Effusions & Synovial Fluid Analysis

9 Chapter 9: Laboratory Operations, Quality Assessment & Safety

9.1 The Total Testing Process: Preanalytical, Analytical & Postanalytical Quality 9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules 9.3 Laboratory Mathematics: Dilutions, Concentration, Molarity & Standard Curves 9.4 Method Evaluation, Diagnostic Statistics & Point-of-Care Testing 9.5 Regulatory Framework, Proficiency Testing & Competency Assessment 9.6 Laboratory Safety: Bloodborne Pathogens, Personal Protective Equipment & Chemical Hygiene 9.7 Emergency Response, Spill Management & Specimen Packaging and Transport 9.8 Hematology Instrumentation: Microscopy, Counters, Analyzers & Centrifuges

1.3 Leukocyte Kinetics, Morphology & Phagocytic Function

Key Takeaways Explain This Topic AI

Granulopoiesis progresses from myeloblast to promyelocyte (characterized by primary azurophilic granules containing myeloperoxidase [MPO]), myelocyte (first appearance of secondary specific granules; final mitotic stage), metamyelocyte (kidney-bean nuclear indentation <50%), band (>50% indentation without thread-like filament), and segmented neutrophil (2–5 lobes).

Vascular neutrophil kinetics maintain a 1:1 equilibrium between the Circulating Granulocyte Pool (CGP, sampled during venipuncture) and the Marginal Granulocyte Pool (MGP, adhering to endothelial walls); acute stress or epinephrine induces rapid demargination (pseudoneutrophilia) without marrow discharge or left shift.

The phagocytic sequence comprises directional chemotaxis (directed by C5a, LTB4, IL-8), opsonization (IgG1, IgG3, C3b), adhesion via β2-integrins (CD11b/CD18), ingestion into a phagosome, and degranulation.

Oxygen-dependent bactericidal killing requires the respiratory burst: multi-component NADPH oxidase generates superoxide (•O2-), Superoxide Dismutase yields H2O2, and primary granule MPO combines H2O2 with chloride to produce hypochlorous acid (HOCl); genetic defects in NADPH oxidase cause Chronic Granulomatous Disease (CGD).

Eosinophils mediate helminthic parasite killing via Major Basic Protein and yield Charcot-Leyden crystals; Basophils express high-affinity FcεRI receptors and release histamine and heparin during anaphylaxis; Monocytes differentiate into resident tissue macrophages (Kupffer cells, microglia, osteoclasts) and present antigens via MHC Class II.

Last updated: August 2026

Leukocyte Kinetics, Morphology & Phagocytic Function

Leukocytes (white blood cells, WBCs) represent the cellular effectors of the innate and adaptive immune systems. In healthy adults, the total peripheral leukocyte count ranges from 4.5 to 11.0 × 10 9 / L 4.5\text{ to }11.0 \times 10^9/\text{L} 4.5 to 11.0 × 1 0 9 / L ( 4 , 500 to 11 , 000 / μ L 4,500\text{ to }11,000/\mu\text{L} 4 , 500 to 11 , 000/ μ L ). Leukocytes are categorized into granulocytes (neutrophils, eosinophils, basophils), mononuclear phagocytes (monocytes and tissue macrophages), and lymphocytes (T-cells, B-cells, NK-cells).

Neutrophilic Granulopoiesis & Maturation Morphology

Under G-CSF and GM-CSF stimulation, neutrophilic granulopoiesis progresses through six morphologic stages within the bone marrow over 10 to 14 days:

Maturation Stage Diameter & N:C Ratio Nuclear Morphology & Chromatin Cytoplasmic Features & Granularity Diagnostic Markers & Mitotic Potential

Myeloblast 14–20 μ m \mu\text{m} μ m ; N:C 7:1 to 4:1 Round/oval; delicate, finely reticulated euchromatin; 2–5 distinct pale nucleoli Scant basophilic cytoplasm; agranular or rare dispersed non-specific azurophilic granules Active mitosis; immunophenotype: CD34+, CD117+, CD33+, CD13+ ; MPO cytochemically negative or faintly positive.

Promyelocyte 15–25 μ m \mu\text{m} μ m ; N:C 5:1 to 3:1 Large, round/oval; condensing chromatin; visible or obscured nucleoli Abundant basophilic cytoplasm filled with prominent, coarse, dark reddish-purple Primary (Azurophilic) Granules ; prominent pale perinuclear Golgi clear zone Active mitosis; primary granules contain: Myeloperoxidase (MPO) , Neutrophil Elastase , Lysozyme , Cathepsin G , Defensins , and BPI .

Myelocyte 12–18 μ m \mu\text{m} μ m ; N:C 2:1 to 1:1 Round, oval, or slightly flattened eccentric nucleus; condensed clumped chromatin; no visible nucleoli Cytoplasm transitions to neutral pink-tan ( "dawn of neutrophilia" ) due to synthesis of fine Secondary (Specific) Granules ; primary granules are diluted LAST STAGE CAPABLE OF MITOTIC DIVISION ; secondary granules contain: Lactoferrin , Transcobalamin I , Collagenase , Gelatinase , and Lysozyme (lacks MPO).

Metamyelocyte 10–15 μ m \mu\text{m} μ m ; N:C 1.5:1 Indented / kidney-bean-shaped nucleus ; nuclear indentation is < 50 % < 50\% < 50% of the width of a hypothetical round nucleus; condensed chromatin Neutral pink/salmon cytoplasm packed with fine secondary and tertiary granules Post-mitotic (marrow maturation pool); incapable of cell division; expresses surface CD11b/CD18 and CD15 .

Band Neutrophil 10–15 μ m \mu\text{m} μ m ; N:C 1:1 Curved, elongated U-, C-, or S-shaped nucleus with parallel sides; nuclear indentation is > 50 % > 50\% > 50% , but chromatin bridge retains visible pattern (no thread-like filament) Abundant pale pink cytoplasm filled with fine secondary and secretory granules Post-mitotic; normal peripheral blood reference range: 0% to 5% ( 0.0 to 0.5 × 10 9 / L 0.0\text{ to }0.5 \times 10^9/\text{L} 0.0 to 0.5 × 1 0 9 / L ).

Segmented Neutrophil (PMN) 10–15 μ m \mu\text{m} μ m ; N:C 1:1 2 to 5 distinct nuclear lobes connected by thin, hair-like chromatin filaments devoid of internal chromatin pattern Abundant pale pink/salmon cytoplasm packed with secondary, tertiary, and secretory granules Fully functional phagocyte; normal peripheral blood reference range: 50% to 70% ( 1.7 to 7.5 × 10 9 / L 1.7\text{ to }7.5 \times 10^9/\text{L} 1.7 to 7.5 × 1 0 9 / L , ASCP BOC composite range) ; lifespan in blood ~6–8 hours.

Neutrophil Kinetics & Compartmental Dynamics

The neutrophil life cycle is distributed across three anatomical compartments:

Bone Marrow Compartment:

Mitotic / Proliferating Pool: Myeloblasts, promyelocytes, and myelocytes (~3–5 days; cells undergo 4–5 cell divisions).

Maturation & Storage Pool: Metamyelocytes, bands, and segmented neutrophils (~5–7 days; stores a 5- to 10-day supply of mature granulocytes awaiting release).

Vascular Compartment (Circulatory Half-Life ~6 to 8 Hours): Total blood granulocytes are split in a dynamic 1 : 1 1:1 1 : 1 equilibrium between:

Circulating Granulocyte Pool (CGP): Neutrophils moving freely in the axial laminar bloodstream; sampled during venipuncture and measured on the automated CBC.

Marginal Granulocyte Pool (MGP): Neutrophils rolling along and adhering to post-capillary venular endothelial cells via selectin-integrin interactions.

Tissue Compartment (Lifespan ~1 to 2 Days): Neutrophils diapedese across endothelial junctions into tissues, execute phagocytosis, and undergo programmed apoptosis, followed by clearance by tissue macrophages. [ BONE MARROW ]

  • [ Mitotic Pool (Myeloblast, Promyelocyte, Myelocyte) ] (3-5 days)
  • │
  • ▼
  • [ Maturation/Storage Pool (Meta, Band, Seg) ] (5-7 days)
  • │
  • ▼ (Marrow Egress)
  • [ VASCULAR COMPARTMENT ]
  • ┌─────────────────────────────┴─────────────────────────────┐
  • ▼ ▼
  • [ Circulating Granulocyte Pool (CGP) ] ◄════════► [ Marginal Granulocyte Pool (MGP) ]
  • (50% of Blood Granulocytes; Counted on CBC) (1:1 Eq) (50% of Blood Granulocytes; Rolling on Endothelium)
  • │ │
  • └─────────────────────────────┬─────────────────────────────┘
  • ▼ (Diapedesis / Chemotaxis)
  • [ TISSUE COMPARTMENT ]
  • (Phagocytosis ──> Respiratory Burst ──> Apoptosis / Macrophage Clearance)
  • Clinical Distinction: Kinetic Shifts in Neutrophil Counts

Demargination (Pseudoneutrophilia / Shift Neutrophilia): Physical exertion, intense emotional stress, pain, trauma, or exogenous epinephrine causes rapid detachment of granulocytes from the vascular endothelium, shifting cells from the MGP into the CGP. This transiently doubles the measured WBC and absolute neutrophil count (ANC) within minutes without bone marrow release and without a left shift (band count remains normal).

Corticosteroid Effect: Therapeutic glucocorticoids (e.g., prednisone) produce leukocytosis by: (1) accelerating the release of mature neutrophils from the bone marrow storage pool, (2) downregulating L-selectin (CD62L) to inhibit neutrophil diapedesis into peripheral tissues, and (3) shifting cells from MGP to CGP. Characteristically accompanied by marked eosinopenia and lymphopenia .

True Reactive Neutrophilia (Infection / Inflammation): Bacterial endotoxins, IL-1, TNF- α \alpha α , and G-CSF drive massive release of the marrow storage pool into circulation within hours, followed by accelerated granulopoiesis. Produces neutrophilia accompanied by a left shift (elevated bands, metamyelocytes, myelocytes) and toxic changes (toxic granulation [persisting active primary granules], Döhle bodies [lamellar aggregates of rough endoplasmic reticulum / ribosomal RNA], and cytoplasmic vacuoles [autophagocytosis]).

The Phagocytic Cascade & Respiratory Burst Biochemistry

Neutrophils eliminate bacterial and fungal pathogens through a five-step sequential cascade: 1. CHEMOTAXIS ──> Directional migration along chemoattractant gradient (C5a, LTB4, IL-8, fMLP)

  • 2. OPSONIZATION ──> Pathogen coating by host opsonins (IgG1, IgG3, C3b, iC3b)
  • 3. ADHERENCE ──> Firm binding via FcγRs (CD64/32/16) and Integrins (CD11b/CD18, CR1)
  • 4. INGESTION ──> Pseudopod engulfment forming an internalized Phagosome
  • 5. DEGRANULATION ──> Primary & secondary granule fusion forming the Phagolysosome
  • │
  • ▼
  • [ RESPIRATORY BURST (OXYGEN-DEPENDENT KILLING) ]
  • Step 1: NADPH Oxidase Complex (gp91phox, p22phox, p47phox, p67phox, Rac2)
  • NADPH + 2 O2 ──> NADP+ + H+ + 2 •O2- (Superoxide Radical)
  • Step 2: Superoxide Dismutase (SOD)
  • 2 •O2- + 2 H+ ──> H2O2 (Hydrogen Peroxide) + O2
  • Step 3: Myeloperoxidase (MPO from Primary Granules)
  • H2O2 + Cl- ──> HOCl (Hypochlorous Acid / Bleach) + OH-

Chemotaxis: Granulocytes migrate directionally toward chemical attractants: complement cleavage fragment C5a , arachidonic acid metabolite leukotriene LTB 4 \text{LTB}_4 LTB 4 ​ , chemokine IL-8 (CXCL8) , and bacterial formyl peptides ( fMLP ).

Opsonization: Pathogens are coated with host serum proteins ( opsonins ) to facilitate recognition: Immunoglobulin G (subclasses IgG1 and IgG3) and complement fragments C3b and iC3b .

Recognition & Adherence: Phagocytes bind opsonized pathogens via surface Fc γ \gamma γ receptors (CD64 [Fc γ \gamma γ RI], CD32 [Fc γ \gamma γ RII], CD16 [Fc γ \gamma γ RIII]) and complement receptors (CR1 [CD35], CR3 / Mac-1 / β 2 \beta_2 β 2 ​ -integrin CD11b/CD18 ).

Ingestion & Phagosome Formation: Pseudopodial extensions enclose the pathogen, pinching off into an internalized cytoplasmic vesicle ( phagosome ).

Phagolysosome Fusion & Degranulation: Primary (azurophilic) and secondary granules fuse with the phagosome, discharging microbicidal enzymes and initiating the respiratory burst .

The Respiratory Burst: Enzymatic Pathway & Clinical Disorders

Step 1 — NADPH Oxidase Assembly: A multi-subunit membrane enzyme complex ( g p 91 p h o x gp91^{phox} g p 9 1 p h o x , p 22 p h o x p22^{phox} p 2 2 p h o x , p 47 p h o x p47^{phox} p 4 7 p h o x , p 67 p h o x p67^{phox} p 6 7 p h o x , and Rac2) transfers electrons from NADPH to molecular oxygen, generating superoxide radicals ( ∙ O 2 − \bullet\text{O}_2^- ∙ O 2 − ​ ) : NADPH + 2 O 2 → NADPH Oxidase NADP + + H + + 2 ∙ O 2 − s e m a n t i c \text{NADPH} + 2\,\text{O}_2 \xrightarrow{\text{NADPH Oxidase}} \text{NADP}^+ + \text{H}^+ + 2\,\bullet\text{O}_2^- semantic NADPH + 2 O 2 ​ NADPH Oxidase ​ NADP + + H + + 2 ∙ O 2 − ​ se man t i c

Step 2 — Superoxide Dismutase (SOD): Dismutates superoxide into hydrogen peroxide: 2 ∙ O 2 − + 2 H + → SOD H 2 O 2 + O 2 2\,\bullet\text{O}_2^- + 2\,\text{H}^+ \xrightarrow{\text{SOD}} \text{H}_2\text{O}_2 + \text{O}_2 2 ∙ O 2 − ​ + 2 H + SOD ​ H 2 ​ O 2 ​ + O 2 ​

Step 3 — Myeloperoxidase (MPO): Primary granule MPO catalyzes the reaction between H 2 O 2 \text{H}_2\text{O}_2 H 2 ​ O 2 ​ and chloride ions ( Cl − \text{Cl}^- Cl − ) to synthesize hypochlorous acid (HOCl / bleach) , the most potent bactericidal oxidant: H 2 O 2 + Cl − → MPO HOCl + OH − \text{H}_2\text{O}_2 + \text{Cl}^- \xrightarrow{\text{MPO}} \text{HOCl} + \text{OH}^- H 2 ​ O 2 ​ + Cl − MPO ​ HOCl + OH −

Critical Board Pathology — Chronic Granulomatous Disease (CGD): Inherited defect in NADPH oxidase subunits (most commonly X-linked C Y B B / g p 91 p h o x CYBB / gp91^{phox} C Y BB / g p 9 1 p h o x ). Phagocytes ingest microbes normally but cannot generate superoxide or H 2 O 2 \text{H}_2\text{O}_2 H 2 ​ O 2 ​ , resulting in recurrent life-threatening infections with catalase-positive organisms ( Staphylococcus aureus , Burkholderia cepacia , Serratia marcescens , Nocardia , Aspergillus ) that degrade their own metabolic H 2 O 2 \text{H}_2\text{O}_2 H 2 ​ O 2 ​ . Confirmatory diagnosis: Dihydrorhodamine-123 (DHR) flow cytometry (failure to oxidize non-fluorescent DHR-123 to fluorescent rhodamine-123) or Nitroblue Tetrazolium (NBT) reduction test (fails to reduce yellow NBT to blue insoluble formazan).

Mononuclear Phagocyte System, Eosinophils & Basophils

Cell Lineage Normal Blood Reference Key Morphologic Features Specific Granule Constituents & Cell Markers Primary Biological Functions

Monocyte / Macrophage 2%–11% ( 0.1 – 1.3 × 10 9 / L 0.1\text{--}1.3 \times 10^9/\text{L} 0.1 – 1.3 × 1 0 9 / L ) 12–20 μ m \mu\text{m} μ m ; folded, indented, or cerebriform nucleus; ground-glass blue-grey cytoplasm; fine dust-like granules; vacuoles CD14+, CD64+, CD33+, CD11b+, HLA-DR (MHC II) ; non-specific esterase (NSE) positive Phagocytosis of debris and senescent RBCs (iron recycling); processing and antigen presentation to CD4 + \text{CD4}^+ CD4 + T-cells; secretion of IL-1, TNF- α \alpha α , IL-6. Differentiates in tissues into Kupffer cells (liver), alveolar macrophages (lungs), microglia (CNS), osteoclasts (bone), and histiocytes (spleen).

Eosinophil 1%–3% ( 0 – 0.3 × 10 9 / L 0\text{--}0.3 \times 10^9/\text{L} 0 – 0.3 × 1 0 9 / L ) 12–17 μ m \mu\text{m} μ m ; characteristically bilobed nucleus ; cytoplasm packed with large, uniform, spherical orange-red / brick-red granules Major Basic Protein (MBP) , Eosinophil Cationic Protein (ECP) , Eosinophil Peroxidase (EPO) , Histaminase ; CD125 (IL-5R α \alpha α ), CD9, CD11b Cytotoxic defense against helminthic parasite larvae; modulation of immediate hypersensitivity / allergic reactions by inactivating histamine and leukotrienes. Degranulated eosinophil lysophospholipase forms hexagonal Charcot-Leyden crystals in tissues/sputum.

Basophil 0%–2% ( 0.0 – 0.2 × 10 9 / L 0.0\text{--}0.2 \times 10^9/\text{L} 0.0 – 0.2 × 1 0 9 / L ) 10–14 μ m \mu\text{m} μ m ; unsegmented or bilobed nucleus obscured by coarse, water-soluble dark purple-black granules Histamine , Heparin , Chondroitin sulfate , Leukotriene LTC 4 \text{LTC}_4 LTC 4 ​ ; high-affinity Fc ϵ RI \text{Fc}\epsilon\text{RI} Fc ϵ RI receptor (binds IgE), CD123, CD203c Primary mediator of immediate Type I hypersensitivity (systemic anaphylaxis, asthma, urticaria); IgE cross-linking triggers rapid explosive degranulation releasing histamine (vasodilation, bronchoconstriction). Marked basophilia is a hallmark of Chronic Myeloid Leukemia (CML) and other MPNs.

Reference Intervals Used on the BOC Examination

Leukocyte reference intervals differ between textbooks. The ASCP BOC publishes a single composite reference range table in the H/SH content guideline and states that all corresponding laboratory values on the examination can be interpreted using these ranges . The composite adult differential values are WBC 3.6–10.6 × 10 9 \times 10^9 × 1 0 9 /L , neutrophils 50–70% (1.7–7.5 × 10 9 \times 10^9 × 1 0 9 /L) , lymphocytes 18–42% (1.0–3.2 × 10 9 \times 10^9 × 1 0 9 /L) , monocytes 2–11% (0.1–1.3 × 10 9 \times 10^9 × 1 0 9 /L) , eosinophils 1–3% (0–0.3 × 10 9 \times 10^9 × 1 0 9 /L) , and basophils 0–2% (0–0.2 × 10 9 \times 10^9 × 1 0 9 /L) . The tables in this section use those values. When a practice question from another source uses a wider interval (e.g., neutrophils 40–70%), classify the result using the BOC composite range instead — the full table is reproduced in Section 9.1.